arrow
N

Nicholas J. Slipek

University of Minnesota
H指数:13
被引数:811

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells

一种用于免疫细胞多功能多重工程化的单碱基编辑平台

2026-07-180
OAAI
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers

基于CRISPR/Cas9的细胞因子诱导的SH2蛋白敲除肿瘤浸润淋巴细胞在胃肠道癌症中的临床制备

2025-06-210
PRE
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing

通过非病毒工程和高通量多重碱基编辑增强CAR-NK细胞的精确性

2025-05-070
OA
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
2024-06-012
OAAI
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair

通过同源性介导的末端连接DNA修复在原代人T细胞中Cas9-induced大DNA有效载荷的靶向整合

2023-12-138
PRE
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
MED
IF11.8
2022-10-0125
OA
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
2021-04-2366
OAAI
Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma
2020-12-0213
OAAI
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
BONE
IF3.6
2020-07-0127
PREAI